Raymond James Financial Inc. Purchases Shares of 287,302 Integer Holdings Co. (NYSE:ITGR)

Raymond James Financial Inc. bought a new position in Integer Holdings Co. (NYSE:ITGR - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 287,302 shares of the medical equipment provider's stock, valued at approximately $38,073,000. Raymond James Financial Inc. owned about 0.86% of Integer as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Loomis Sayles & Co. L P grew its holdings in Integer by 3.0% during the 3rd quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider's stock worth $69,943,000 after acquiring an additional 15,446 shares during the last quarter. Jane Street Group LLC grew its holdings in Integer by 23.3% during the 3rd quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider's stock worth $19,682,000 after acquiring an additional 28,572 shares during the last quarter. Verition Fund Management LLC grew its holdings in Integer by 17.4% during the 3rd quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider's stock worth $451,000 after acquiring an additional 515 shares during the last quarter. Versant Capital Management Inc grew its holdings in Integer by 98.4% during the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock worth $49,000 after acquiring an additional 183 shares during the last quarter. Finally, KBC Group NV grew its holdings in Integer by 83.3% during the 4th quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider's stock worth $212,000 after acquiring an additional 726 shares during the last quarter. Institutional investors own 99.29% of the company's stock.

Remove Ads

Integer Trading Down 0.5 %

Integer stock traded down $0.64 during midday trading on Friday, hitting $117.76. 2,991,416 shares of the stock were exchanged, compared to its average volume of 369,482. The company has a fifty day simple moving average of $134.11 and a two-hundred day simple moving average of $132.72. Integer Holdings Co. has a 52 week low of $107.11 and a 52 week high of $146.36. The stock has a market capitalization of $3.96 billion, a PE ratio of 35.05, a P/E/G ratio of 1.72 and a beta of 1.24. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing the consensus estimate of $1.46 by ($0.03). Integer had a return on equity of 11.65% and a net margin of 6.92%. The firm had revenue of $449.50 million for the quarter, compared to the consensus estimate of $446.28 million. Equities research analysts anticipate that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ITGR has been the topic of a number of research analyst reports. Benchmark increased their price objective on shares of Integer from $140.00 to $150.00 and gave the stock a "buy" rating in a report on Friday, February 21st. Truist Financial lifted their price target on shares of Integer from $147.00 to $163.00 and gave the stock a "buy" rating in a research report on Wednesday, December 11th. KeyCorp lifted their price target on shares of Integer from $144.00 to $154.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Oppenheimer cut shares of Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Finally, Wells Fargo & Company reiterated an "overweight" rating and set a $160.00 price target on shares of Integer in a research report on Tuesday, December 3rd. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $149.00.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.